Source: Journal of Infectious Diseases. Unidades: ICB, FM
Subjects: IMUNOLOGIA, ADJUVANTES IMUNOLÓGICOS, HIV, INFECÇÕES POR HIV, RECÉM-NASCIDO, MACRÓFAGOS, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, INTERFERON TIPO I, MONÓCITOS
ABNT
PIETROBON, Anna Julia et al. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages. Journal of Infectious Diseases, v. 225, n. 3, p. 510–519, 2022Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiab389. Acesso em: 17 nov. 2024.APA
Pietrobon, A. J., Yoshikawa, F. S. Y., Oliveira, L. M., Pereira, N. Z., Souza, T. A. M. de, Bargieri, B. C. de A., et al. (2022). Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages. Journal of Infectious Diseases, 225( 3), 510–519. doi:10.1093/infdis/jiab389NLM
Pietrobon AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, Souza TAM de, Bargieri BC de A, Duarte AJ da S, Sato MN. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages [Internet]. Journal of Infectious Diseases. 2022 ; 225( 3): 510–519.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1093/infdis/jiab389Vancouver
Pietrobon AJ, Yoshikawa FSY, Oliveira LM, Pereira NZ, Souza TAM de, Bargieri BC de A, Duarte AJ da S, Sato MN. Antiviral response induced by toll-like receptor (TLR) 7/TLR8 activation inhibits human immunodeficiency virus Type 1 infection in cord blood macrophages [Internet]. Journal of Infectious Diseases. 2022 ; 225( 3): 510–519.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1093/infdis/jiab389